tiprankstipranks
Boston Scientific price target raised to $107 from $98 at Citi
The Fly

Boston Scientific price target raised to $107 from $98 at Citi

Citi raised the firm’s price target on Boston Scientific (BSX) to $107 from $98 and keeps a Buy rating on the shares. The firm also added the shares to Citi’s Focus List. It expects momentum of the shares to continue in 2025. Next year’s growth drivers should be a continuation of the 2024 story – continuing to expand Farapulse pulsed-field ablation and Watchman left atrial appendage closure adoption and penetration, the analyst tells investors in a research note.

Pick the best stocks and maximize your portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App